120 related articles for article (PubMed ID: 34351630)
1. Fixed erythrodysesthesia plaques at sites of intravenous docetaxel infusion: an unusual cutaneous reaction to chemotherapy.
Cutler L; Wang H; Kim G; Chiu M
Int J Dermatol; 2022 Aug; 61(8):e316-e317. PubMed ID: 34351630
[No Abstract] [Full Text] [Related]
2. Chemotherapy-induced erythrodysesthesia of the breast.
Alcalde-Castro J; Soto-Perez-de-Celis E; Reyes-Gutiérrez E; Orozco-Topete R; León-Rodríguez E; Chávarri-Guerra Y
Breast J; 2018 Sep; 24(5):828-830. PubMed ID: 29738105
[No Abstract] [Full Text] [Related]
3. Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.
Eich D; Scharffetter-Kochanek K; Eich HT; Tantcheva-Poor I; Krieg T
Am J Clin Oncol; 2002 Dec; 25(6):599-602. PubMed ID: 12478008
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel induced severe palmar plantar erythrodysesthesia.
Kharmoum S; Errihani H
Pan Afr Med J; 2018; 30():70. PubMed ID: 30344854
[No Abstract] [Full Text] [Related]
5. Docetaxel-induced palmoplantar erythrodysesthesia syndrome and long-lasting multiple nail changes.
Akoglu G
Indian J Pharmacol; 2014; 46(2):225-7. PubMed ID: 24741199
[TBL] [Abstract][Full Text] [Related]
6. Influence of Chemotherapy on the Antioxidant Status of Human Skin.
Lee BN; Jung S; Darvin ME; Eucker J; Kühnhardt D; Sehouli J; Chekerov R; Patzelt A; Fuss H; Yu RX; Lademann J
Anticancer Res; 2016 Aug; 36(8):4089-93. PubMed ID: 27466518
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin for Treatment of Docetaxel-Related Hand-Foot Syndrome.
Orare K; Nambafu J; Mwanzi S; Ali SK
J Pain Symptom Manage; 2019 Jul; 58(1):e1-e2. PubMed ID: 30974234
[No Abstract] [Full Text] [Related]
8. Rapidly developing facial and intertriginous hyperpigmentation with acral erythema after docetaxel infusion.
Eryılmaz MK; Tazegul G; Ünal B; Müsri FY; Güzel HG; Coşkun HŞ
J Cancer Res Ther; 2021; 17(1):293-294. PubMed ID: 33723176
[No Abstract] [Full Text] [Related]
9. Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer.
Decoster L; Fontaine C; Vanacker L; Schallier D; De Grève J
Breast J; 2018 Jul; 24(4):695-697. PubMed ID: 29286203
[No Abstract] [Full Text] [Related]
10. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
Belani CP
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer.
Bi Z; Chen P; Liu YB; Zhao T; Sun X; Song XR; Wang YS
Breast Cancer Res Treat; 2020 Nov; 184(2):397-405. PubMed ID: 32776291
[TBL] [Abstract][Full Text] [Related]
12. [Study on the adverse reactions related to paclitaxel and docetaxel infusion].
Castro IJ; Pons Busom M; Ballesteros Cabañas GI; Ramió Montero E; Alvarez Méndez A; De Castro Chivato R; Centelles Ruiz M
Farm Hosp; 2013; 37(2):88-94. PubMed ID: 23789752
[TBL] [Abstract][Full Text] [Related]
13. Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer.
Perachino M; Poggio F; Lambertini M
Breast Cancer Res Treat; 2020 Aug; 183(1):239-240. PubMed ID: 32596767
[No Abstract] [Full Text] [Related]
14. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
Nyrop KA; Deal AM; Reeder-Hayes KE; Shachar SS; Reeve BB; Basch E; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
Cancer; 2019 Sep; 125(17):2945-2954. PubMed ID: 31090930
[TBL] [Abstract][Full Text] [Related]
16. Hand-foot syndrome caused by docetaxel with no recurrence after switch to paclitaxel, a different taxane.
Corazza M; Minghetti S; Borghi A; Virgili A; Ballardini P
Int J Dermatol; 2014 Mar; 53(3):e180-2. PubMed ID: 23621794
[No Abstract] [Full Text] [Related]
17. Local erythematous dermatitis after intravenous docetaxel.
Hirai K; Ishiko O; Nakajima S; Kanaoka Y; Nakamura Y; Oiso N; Ishii M; Ogita S
Gynecol Obstet Invest; 2002; 53(2):118-20. PubMed ID: 11961387
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel in combination with fluorouracil for advanced solid tumors.
Burris HA
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):50-2. PubMed ID: 9364544
[TBL] [Abstract][Full Text] [Related]
19. Definitive alopecia post-docetaxel.
Ben Kridis W; Khanfir A
Breast J; 2020 Apr; 26(4):792-793. PubMed ID: 31541513
[No Abstract] [Full Text] [Related]
20. Paclitaxel-induced dorsal hand-foot syndrome.
Quan EY; Engel C; Rush PS; Eikenberg JD
Dermatol Online J; 2023 Jun; 29(3):. PubMed ID: 37591274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
